| Latest | F'cast | |
|---|---|---|
| Div Yield | 7.5% | 0.0% |
| Div Cover | 1.0 | n/a |
| Op Mrgn | 77.8% | 76.2% |
| ROCE | 78.6% |
| Latest | F'cast | |
|---|---|---|
| P/E | 13.8 | n/a |
| PEG | 42.6 | n/a |
| Pr/Revenue | 8.1 | n/a |
| Pr/Book | 9.2 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -1.1% | n/a |
| PBT | 1.3% | -100.0% |
| EPS | 0.3% | n/a |
| DPS | n/a | -100.0% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-22 | 11.72 | 9.28 | 147.32p | 23.4 | 1.7 | +14% | 126.00p | 3.7% |
| 30-Jun-23 | 12.82 | 10.13 | 160.63p | 24.0 | 2.7 | +9% | 152.00p | 3.9% |
| 30-Jun-24 | 13.61 | 10.60 | 155.12p | 28.4 | n/a | -3% | 155.00p | 3.5% |
| 30-Jun-25 | 13.12 | 10.10 | 145.27p | 18.9 | n/a | -6% | 150.00p | 5.5% |
| 30-Jun-26 | 12.97 | 10.23 | 145.74p | 11.1 | n/a | 0% | 150.00p | 9.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Bioventix Forecasts data is not available for this company.
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Holding(s) in Company | 30-Oct-2026 | 17:00 | RNS |
| Results for the year ended 30 June 2026 | 26-Oct-2026 | 07:00 | RNS |
| Director Dealing | 24-Jun-2026 | 16:10 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1,966.67p |
| Change Today | -58.33p |
| % Change | -2.88 % |
| 52 Week High | 2,200.00 |
| 52 Week Low | 1,366.67 |
| Volume | 73,058 |
| Shares Issued | 5.22m |
| Market Cap | £102.76m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| Latest | Previous | |
|---|---|---|
| 2nd Interim | Interim | |
| Ex-Div | 05-Nov-26 | 09-Apr-26 |
| Paid | 20-Nov-26 | 24-Apr-26 |
| Amount | 80.00p | 70.00p |
| Time | Volume / Share Price |
| 14:48 | 600 @ 1,966.25p |
| 14:42 | 224 @ 1,966.10p |
| 14:42 | 150 @ 1,992.50p |
| 14:38 | 775 @ 1,992.00p |
| 14:33 | 118 @ 1,966.10p |
| CEO | Peter John Harrison |
| Chair | Ian James Nicholson |
| CFO | Bruce Hiscock |
You are here: research